Drug Profile
AZD 7806
Alternative Names: AZD7806Latest Information Update: 03 Apr 2006
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antihyperlipidaemics
- Mechanism of Action Sodium-bile acid cotransporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Lipid metabolism disorders
Most Recent Events
- 02 Feb 2006 Discontinued - Phase-I for Lipid metabolism disorders (unspecified route)
- 20 Jun 2005 This compound is still in active development
- 22 Jul 2004 Phase-I clinical trials in Lipid metabolism disorders (unspecified route)